Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Vemurafenib × 90 days × Clear all

Phase

Status

Sponsor Class

OTHER 7 INDUSTRY 3 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1

Interventions

Specimen Handling 39 Magnetic Resonance Spectroscopy 34 Cyclophosphamide 24 Vincristine 20 Radiation 20 Cisplatin 19 Carboplatin 19 Etoposide 16 Radiotherapy 15 Biopsy 14 Irinotecan 12 Doxorubicin 12 Dexamethasone 11 Methotrexate 10 Radiotherapy, Intensity-Modulated 9 Platinum 9 Observation 9 Leucovorin 9 Gemcitabine 9 Cytarabine 9 1,2-diaminocyclohexaneplatinum II citrate 9 fludarabine 8 X-Rays 8 Stem Cell Transplantation 8 Fluorouracil 8 merphos 7 dehydroftorafur 7 daratumumab 7 Watchful Waiting 7 Triptorelin Pamoate 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297606 2026-03-04

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡